Dapagliflozin tied to significant reduction in ventricular repolarization parameters in CVD patients with glycemic control Dr.Niharika Harsha B13 July 2023 10:45 AM ISTNew research revealed that Dapagliflozin exerts antihyperglycemic effects irrespective of the cardiovascular disease status and also reduces the risk...
Albuminuric diabetic kidney disease may increase risk of Diabetic Foot Ulcer by two to three folds Aditi19 Jan 2023 10:30 AM ISTFrance: According to a recent research paper published in the Journal of Diabetes And its Complications, the researchers have concluded that in type...
ECG Abnormalities common in T2D patients even without history of CVD: Study MD Bureau13 March 2021 1:00 AM ISTPeople with type 2 diabetes have a two-fold higher risk of cardiovascular disease (CVD) compared to the general population. In a recent study,...
